Sartorius Historical Cash Flow
| 0RG8 Stock | 197.30 0.10 0.05% |
Analysis of Sartorius Stedim cash flow over time is an excellent tool to project Sartorius Stedim Biotech future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Dividends Paid of 140.2 M or Capital Expenditures of 0.0 as it is a great indicator of Sartorius Stedim ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Sartorius Stedim Biotech latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Sartorius Stedim Biotech is a good buy for the upcoming year.
Sartorius |
About Sartorius Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Sartorius balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Sartorius's non-liquid assets can be easily converted into cash.
Sartorius Stedim Cash Flow Chart
Add Fundamental
Dividends Paid
The total amount of dividends that a company has paid out to its shareholders over a specific period.Net Income
Net income is one of the most important fundamental items in finance. It plays a large role in Sartorius Stedim Biotech financial statement analysis. It represents the amount of money remaining after all of Sartorius Stedim Biotech operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.Most accounts from Sartorius Stedim's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Sartorius Stedim Biotech current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Sartorius Stedim Biotech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. At this time, Sartorius Stedim's Depreciation is comparatively stable compared to the past year. Dividends Paid is likely to gain to about 140.2 M in 2025, whereas Change In Working Capital is likely to drop (149.6 M) in 2025.
| 2021 | 2022 | 2024 | 2025 (projected) | Dividends Paid | 62.7M | 116.1M | 133.5M | 140.2M | Depreciation | 126.4M | 162.3M | 186.6M | 196.0M |
Sartorius Stedim cash flow statement Correlations
Click cells to compare fundamentals
Sartorius Stedim Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Sartorius Stedim cash flow statement Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Change In Cash | 4.2M | 31.6M | 163.8M | (116.5M) | (134.0M) | (127.3M) | |
| Total Cashflows From Investing Activities | (184.4M) | (621.1M) | (465.2M) | (957.5M) | (861.8M) | (818.7M) | |
| Other Cashflows From Financing Activities | (9.8M) | (34.1M) | (9.5M) | (52.4M) | (47.2M) | (44.8M) | |
| Depreciation | 64.3M | 86.7M | 126.4M | 162.3M | 186.6M | 196.0M | |
| Dividends Paid | 52.5M | 31.3M | 62.7M | 116.1M | 133.5M | 140.2M | |
| Capital Expenditures | 176.5M | 136.0M | 159.2M | 324M | 430.6M | 0.0 | |
| Total Cash From Operating Activities | 310.1M | 416.9M | 701.9M | 612.3M | 704.1M | 408.5M | |
| Net Income | 357.8M | 414.4M | 876.1M | 309.7M | 356.2M | 389.7M | |
| Total Cash From Financing Activities | (122.2M) | 234.1M | (77.7M) | 220.7M | 253.8M | 266.5M | |
| Other Cashflows From Investing Activities | (1K) | 8.7M | 500K | (11.3M) | (13.0M) | (13.6M) | |
| Change To Inventory | (66.0M) | (116.6M) | (275.4M) | (217.9M) | (196.1M) | (205.9M) | |
| Net Borrowings | (59.8M) | 299.5M | (5.5M) | 392.4M | 451.3M | 473.8M | |
| Change To Account Receivables | 3.8M | (73.9M) | (87.3M) | (65.8M) | (59.2M) | (62.2M) | |
| Change To Operating Activities | 31.9M | 146.9M | 217M | (67.6M) | (60.8M) | (57.8M) | |
| Change To Netincome | 32.4M | 22.9M | 291.6M | (94.2M) | (108.3M) | (102.9M) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| BTC | Bitcoin | |
| TRX | TRON | |
| BNB | Binance Coin |
Additional Tools for Sartorius Stock Analysis
When running Sartorius Stedim's price analysis, check to measure Sartorius Stedim's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sartorius Stedim is operating at the current time. Most of Sartorius Stedim's value examination focuses on studying past and present price action to predict the probability of Sartorius Stedim's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sartorius Stedim's price. Additionally, you may evaluate how the addition of Sartorius Stedim to your portfolios can decrease your overall portfolio volatility.